Anywaine, Z., Whitworth, H., Kaleebu, P., Praygod, G., Shukarev, G., Manno, D., ... y Watson-Jones, D. (2019). Safety and immunogenicity of a 2-dose heterologous vaccination regimen with Ad26. ZEBOV and MVA-BN-Filo Ebola vaccines: 12-month data from a phase 1 randomized clinical trial in Uganda and Tanzania. The Journal of infectious diseases, 220(1), 46-56. https://doi.org/10.1093/infdis/jiz070